[172]
Apotex' central argument is that the inventors were merely verifying predictable qualities of known compounds. This argument fails because verification means
confirming
predicted or predictable qualities of
known
compounds that have
already been discovered and made; therefore, one cannot "verify" unexpected and unpredictable properties of new compounds.
(
Pfizer v. Ratiopharm
, above at para. 24;
AB Hassle v. Genpharm
, above at para. 51;
Sanofi-Synthelabo v. Apotex
, above at para. 76;
Bayer Aktiengesellschaft
, above at 81.)